Annals of Surgical Oncology

, Volume 18, Issue 8, pp 2348–2356

Role of MMP14 Gene Polymorphisms in Susceptibility and Pathological Development to Hepatocellular Carcinoma

  • Tzy-Yen Chen
  • Yi-Ching Li
  • Yu-Fan Liu
  • Chiung-Man Tsai
  • Yi-Hsien Hsieh
  • Chiao-Wen Lin
  • Shun-Fa Yang
  • Chia-Jui Weng
Translational Research and Biomarkers

DOI: 10.1245/s10434-011-1574-x

Cite this article as:
Chen, T., Li, Y., Liu, Y. et al. Ann Surg Oncol (2011) 18: 2348. doi:10.1245/s10434-011-1574-x

Abstract

Background

Early detection of hepatocellular carcinoma (HCC) is seldom available because of the lack of reliable markers. Matrix metalloproteinase (MMP) 14 is a cell surface proteinase that displays a broad spectrum of activity against extracellular matrix components and promotes the invasion/metastasis of cells. MMP14 is overexpressed in HCC, and the level is correlated with poor overall survival. The purpose of this study was to examine whether the MMP14 gene polymorphisms are associated with the susceptibility and clinicopathological development of HCC.

Methods

A total of 135 patients with HCC and 496 healthy control subjects were recruited. Six single nucleotide polymorphisms (SNPs) of MMP14 genes were analyzed by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) genotyping and haplotype-base analysis.

Results

A significant (p < 0.05) lower risk for HCC was shown in the individuals with MMP14 +6767 G/A and +7096 C/C genotypes compared with those with corresponding wild-type homozygotes; high frequency for anti-hepatitis C virus and cirrhosis positive were shown in the HCC patients with MMP14 +7096 TC/CC genotype after adjusting for other confounding factors. The distribution frequency of −165 T: +221 T: +6727 C: +6767 G: +7096 T: +8153 G haplotype and diplotype was significantly higher in the HCC patients than healthy control subjects.

Conclusions

The +6767 and +7096 polymorphic genotypes and haplotype −165 T: +221 T: +6727 C: +6767 G: +7096 T: +8153 G of MMP14 gene might contribute to the prediction of susceptibility and pathological development to HCC.

Copyright information

© Society of Surgical Oncology 2011

Authors and Affiliations

  • Tzy-Yen Chen
    • 1
    • 2
  • Yi-Ching Li
    • 3
    • 4
  • Yu-Fan Liu
    • 5
  • Chiung-Man Tsai
    • 6
  • Yi-Hsien Hsieh
    • 7
  • Chiao-Wen Lin
    • 7
  • Shun-Fa Yang
    • 4
    • 8
  • Chia-Jui Weng
    • 9
  1. 1.School of MedicineChung Shan Medical UniversityTaichungTaiwan
  2. 2.Department of Internal MedicineChung Shan Medical University HospitalTaichungTaiwan
  3. 3.Department of Pharmacology, School of MedicineChung Shan Medical UniversityTaichungTaiwan
  4. 4.Department of Medical ResearchChung Shan Medical University HospitalTaichungTaiwan
  5. 5.Department of Biomedical SciencesChung Shan Medical UniversityTaichungTaiwan
  6. 6.Chest Hospital, Department of Health, Executive YuanTainanTaiwan
  7. 7.Institute of Biochemistry and BiotechnologyChung Shan Medical UniversityTaichungTaiwan
  8. 8.Institute of MedicineChung Shan Medical UniversityTaichungTaiwan
  9. 9.Graduate Institute of Applied Science of LivingTainan University of TechnologyTainan CityTaiwan